Skip to main content
VCbacked
Log inGet Started

Corteria Pharmaceuticals

Paris, France

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

$69.5M raised
Sep 2023
Series A
BiotechnologyPharmaceuticalTherapeutics

Top Investors

OrbiMedOmnes CapitalKurma PartnersJeito CapitalV-Bio Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Corteria Pharmaceuticals

How much funding has Corteria Pharmaceuticals raised?
Corteria Pharmaceuticals has raised $69.5M in total funding. The most recent round was Series A. The last funding was announced in September 2023.
Who are Corteria Pharmaceuticals's investors?
Corteria Pharmaceuticals's investors include OrbiMed, Omnes Capital, Kurma Partners, Jeito Capital, V-Bio Ventures.
Where is Corteria Pharmaceuticals headquartered?
Corteria Pharmaceuticals is headquartered in Paris, France.
What does Corteria Pharmaceuticals do?
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
What stage is Corteria Pharmaceuticals at?
Corteria Pharmaceuticals is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Corteria Pharmaceuticals — Funding & Investors." VCBacked, September 7, 2023, https://www.vcbacked.co/company/corteria-pharmaceuticals. Accessed June 17, 2026.
APA
VCBacked. (2023). Corteria Pharmaceuticals — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/corteria-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Corteria Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/corteria-pharmaceuticals |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong